Curanex Dm
Product Images NDC 83335-004

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Curanex Dm (NDC 83335-004). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wittman Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Panel 1 (Curanex Dm Panel 1.jpg)

CuraNEX DM cough suppressant expectorant immediate release tablets. Each tablet contains Dextromethorphan HBr 20 mg and Guaifenesin 400 mg. The label shows the product controls cough and thins and loosens mucus, with a package size of 100 tablets. Manufactured by Wittman Pharma, Inc. in the USA, NDC 83335-004.*

FDA Label Image

Label Panel 2 (Curanex Dm Panel 2.jpg)

This Drug Facts panel continues warnings for CuraNEX DM, advising not to exceed recommended dosage and to consult a doctor if symptoms worsen or persist. It cautions certain groups including pregnant women and breastfeeding mothers to seek medical advice. Directions include taking with water, age-specific dosing frequency, and storage instructions (15-30°C). Inactive ingredients and a customer service contact number are listed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.